Avita Medical | 1811094D - 营业费用



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 367.38M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


营业费用 更改 日
Accuray USD 37.18M 567K 2024-12
Celltrion KRW 119.22B 21.46B 2026-03
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 21.61M 11.59M 2025-12
Nanosonics AUD 93.11M 45.89M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pacific Edge NZD 22.5M 2.84M 2026-06
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
Pharma Mar EUR 51.01M 8.73M 2026-06
Polynovo AUD 68.22M 1.24M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Qiagen NV USD 393.64M 17.95M 2026-06
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 931.6M 9.09M 2026-03
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Telix Pharmaceuticals AUD 430.99M 25.59M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.45B 431.06M 2026-06